Φορτώνει......
Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
To the best of our knowledge, non-vitamin K antagonist oral anticoagulants (NOACs), or direct oral anticoagulants, have not been tested in randomized trials conducted in patients with atrial fibrillation (AF), affected by malignant disease. However, their use in patients with cancer is increasing, w...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Anatol J Cardiol |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Kare Publishing
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7141434/ https://ncbi.nlm.nih.gov/pubmed/31911561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14744/AnatolJCardiol.2019.30766 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|